Showing results (121-130 of 375) with videos related to
Sort By:
Pageof 38
BMC Public Health|August 17, 2005
The impact of changes to heroin supply on blood-borne virus notifications and injecting related harms in New South Wales, AustraliaCarolyn Day, Louisa Degenhardt, Stuart Gilmour, et al.Tobacco Control|December 2, 2016
Medicalisation, smoking and e-cigarettes: evidence and implicationsKylie Morphett, Adrian Carter, Wayne Hall, et al.Community Genetics|May 22, 2008
The implications of genetic susceptibility for the prevention of colorectal cancer: a qualitative study of older adults' understandingJayne Lucke, Wayne Hall, Bree Ryan, et al.BMC Medical Research Methodology|April 4, 2006
Using intervention time series analyses to assess the effects of imperfectly identifiable natural events: a general method and exampleStuart Gilmour, Louisa Degenhardt, Wayne Hall, et al.Substance Abuse Treatment, Prevention, and Policy|October 8, 2021
An overview of select cannabis use and supply indicators pre- and post-legalization in CanadaBenedikt Fischer, Angelica Lee, Tessa Robinson, et al.Journal of Substance Abuse Treatment|July 1, 2020
Support for the psychosocial, disease and brain disease models of addiction: A survey of treatment providers' attitudes in Australia, the UK, and U.SAnthony Barnett, Kerry O'Brien, Wayne Hall, et al.Drug and Alcohol Review|November 6, 2012
Australian university students' attitudes towards the use of prescription stimulants as cognitive enhancers: perceived patterns of use, efficacy and safetyBrad Partridge, Stephanie Bell, Jayne Lucke, et al.Addiction (Abingdon, England)|June 28, 2023
The implementation and public health impacts of cannabis legalization in Canada: a systematic reviewWayne Hall, Daniel Stjepanović, Danielle Dawson, et al.Addiction (Abingdon, England)|March 24, 2005
Evaluating explanations of the Australian 'heroin shortage'Louisa Degenhardt, Peter Reuter, Linette Collins, et al.Addiction (Abingdon, England)|February 28, 2002
Heroin use in New South Wales, Australia, 1996-2000: 5 year monitoring of trends in price, purity, availability and use from the Illicit Drug Reporting System (IDRS)Shane Darke, Ibby Topp, Harlene Kaye, et al.Pageof 38